Sponsor:
National Institutes of Health
UI Contact:
Updated Date:
Oct 30, 2023
The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices and funding opportunities:
Policy Notices
- Adjustments to NIH Grant Application Due Dates on or Between October 28, 2023 and October 31, 2023
(NOT-OD-24-020)
National Institutes of Health
General Notices
- Notice of Participation of the National Institute on Aging (NIA) in NOT-ES-23-016, "Request for Information (RFI): Environmental Justice Research Gaps, Opportunities and Capacity Building"
(NOT-AG-23-068)
National Institute on Aging
- Notice of Pre-Application Webinar for PAR-23-292: Improving Care and Outcomes for Cancer Survivors from Sexual and Gender Minority (SGM) Populations (R01 Clinical Trial Optional)
(NOT-CA-24-005)
National Cancer Institute
- Notice of Pre-Application Webinar for C06 Research Facilities Construction Grants PAR-23-306 and PAR-24-033
(NOT-OD-24-019)
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
- Notice of Information to Publish Notice of Special Interest: Developing and Testing Multilevel Physical Activity Interventions to Improve Health and Well-Being
(NOT-OD-24-021)
Office of Disease Prevention
- Request for Information (RFI): NCI Cancer Research Data Commons (CRDC) Artificial Intelligence (AI) use cases to inform an assessment of data readiness
(NOT-CA-24-002)
National Cancer Institute
Notice of Changes to Funding Opportunities
- Notice of Correction to PAR-22-131, Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Cancer and Precancerous Lesions Associated with Lethal Phenotypes (R01 Clinical Trial Optional)
(NOT-CA-24-004)
National Cancer Institute
- Notice to Extend the Expiration Date of PAR-21-107 NIDCD Early Career Research(ECR) Award (R21 Clinical Trial Optional)
(NOT-DC-24-007)
National Institute on Deafness and Other Communication Disorders
- Notice of Correction to Information Regarding the Locus of Peer Review for Applications Submitted to PAR-23-213 "Interactive Digital Media (IDM) Biomedical Science Resources for Pre-College Students and Teachers (SBIR)"
(NOT-GM-24-008)
National Institute of General Medical Sciences
- Notice of Change to the Funding Opportunity Award Budget of RFA-OD-24-002, R25 for Short Courses on Techniques for Measuring Intimate Partner Violence (IPV) in Different Populations (R25 Clinical Trial Not Allowed)
(NOT-OD-24-015)
Office of Behavioral and Social Sciences Research
- Notice of Change to Expiration Date for PAR-22-233 Time-Sensitive Opportunities for Health Research (R61/R33 Clinical Trial Not Allowed)
(NOT-OD-24-016)
Office of Behavioral and Social Sciences Research
Notices of Intent to Publish
- Notice of Intent to Publish a Funding Opportunity Announcement for Center of Excellence for Systems Modeling of Infection and Immunity across Biological Scales (U54 Clinical Trial Not Allowed)
(NOT-AI-23-073)
National Institute of Allergy and Infectious Diseases
- Notice of Intent to Publish a Funding Opportunity Announcement for NIDCR Mentoring Network to Support a Diverse Dental, Oral and Craniofacial Research Workforce (UE5 Clinical Trial Not Allowed)
(NOT-DE-24-002)
National Institute of Dental and Craniofacial Research
Notices of Special Interest
- Notice of Special Interest (NOSI): Chemical Countermeasures Research Program (CCRP) Initiative: Additional Research Areas of Interest focusing on Ultra-Potent Synthetic (UPS) Opioids
(NOT-DA-23-044)
National Institute on Drug Abuse
National Institute of Allergy and Infectious Diseases
- Notice of Special Interest (NOSI): Applications of Data Science in Translational Dental, Oral, and Craniofacial Research
(NOT-DE-24-003)
National Institute of Dental and Craniofacial Research
- Notice of special interest (NOSI): Adopting Techniques and Tools Developed from the BRAIN Initiative Toward NIMH Strategic Research Priorities
(NOT-MH-24-290)
National Institute of Mental Health
- Notice of Special Interest (NOSI): Administrative Supplements to Recognize Excellence in Diversity, Equity, Inclusion, and Accessibility (DEIA) Mentorship
(NOT-OD-24-001)
Office of the Director, NIH
National Center for Advancing Translational Sciences
National Center for Complementary and Integrative Health
National Cancer Institute
National Eye Institute
National Human Genome Research Institute
National Heart, Lung, and Blood Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Environmental Health Sciences
National Institute of General Medical Sciences
National Institute of Mental Health
National Institute on Minority Health and Health Disparities
National Institute of Nursing Research
National Library of Medicine
Funding Opportunities
- Advancing Hearing and Balance Research Using Auditory and Vestibular Organoids (R21-Clinical Trial Not Allowed)
(PAS-24-057)
National Institute on Deafness and Other Communication Disorders - Advancing Hearing and Balance Research Using Auditory and Vestibular Organoids (R01-Clinical Trial Not Allowed)
(PAS-24-058)
National Institute on Deafness and Other Communication Disorders - Development of Candidate Radiation/Nuclear Medical Countermeasures (MCMs) (U01 Clinical Trial Not Allowed)
(RFA-AI-23-059)
National Institute of Allergy and Infectious Diseases - Engineering and Preclinical Development of Biological Products that Eliminate HIV-infected Cells (UG3/UH3 Clinical Trial Not Allowed)
(RFA-AI-23-060)
National Institute of Allergy and Infectious Diseases - Long-Acting Drug Delivery Systems for ART Optimization in Children Living with HIV-1 II (LADDS II) (R61/R33 Clinical Trial Not Allowed)
(RFA-AI-23-061)
National Institute of Allergy and Infectious Diseases
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Mental Health - Resource Center for Cannabis and Cannabinoid Research (U24 Clinical Trial Not Allowed)
(RFA-AT-24-006)
National Center for Complementary and Integrative Health
National Cancer Institute
National Institute on Aging
National Institute on Drug Abuse - Tools for Decentralized Clinical Trials for Substance Use Disorder (R41/R42 Clinical Trials Optional)
(RFA-DA-25-051)
National Institute on Drug Abuse - Tools for decentralized clinical trials for substance use disorder (R43/R44 Clinical Trials Optional)
(RFA-DA-25-052)
National Institute on Drug Abuse - Single Source for continuation of the Human Pancreas Analysis Program for Type-2 Diabetes (HPAP-T2D) (U01 Clinical Trial Not Allowed)
(RFA-DK-25-002)
National Institute of Diabetes and Digestive and Kidney Diseases
Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at dsp@uiowa.edu or 313-335-2123, or email Ann Ricketts or Lynn Hudachek.